InFlectis BioScience - Company Review
InFlectis BioScience - Company ReviewSummary
InFlectis BioScience (InFlectis) is a drug discovery company that discovers and develops small molecule drugs that target the unfolded protein response (UPR) to treat misfolding protein disorders such as age-related and neurodegenerative diseases. The company’s product lead candidate IFB-088, modulates the UPR through protein-protein interaction and targets neurodegenerative and orphan diseases such as charcot-marie-tooth and retinitis pigmentosa. InFlectis has collaboration with European organization for Rare Diseases (EURORDIS) and Atlanpole for operational and customized support. The company intends to develop other several drug candidates to treat other age related diseases such as Alzheimer’s Parkinson’s, type II Diabetes and some forms of cancer. InFlectis is headquartered in Nantes, France.
This comprehensive company report of InFlectis BioScience provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.